2.6 C
Monday, December 6, 2021

Coronavirus vaccine, Pfizer for children and teenagers. How effective? CDC Research

Must read

- Advertisement -

The COVID-19 vaccine from Pfizer / BioNTech is 93 percent effective in preventing hospitalization in adolescents between the ages of 12 and 18, according to a study published by the U.S. Centers for Disease Control and Prevention (CDC).

The researchers based their study on the period from June to September, when the Delta variant was spreading in the US.

According to the US Centers for Disease Control and Prevention (CDC), the effectiveness of the Pfizer / BioNTech vaccine among people aged 12-18 is 93 percent. This is more than adults, where it is said to be 88 percent effective in preventing hospitalization.

Data from 19 pediatric hospitals showed that 97 percent of 179 people hospitalized with COVID-19 were unvaccinated. 16 percent of those who were hospitalized ended up in intensive care units. Neither of them were vaccinated.

Vaccination of a teenager in the USAETIENNE LAURENT / PAP / EPA

- Advertisement -

Vaccinations against COVID-19 in the United States

So far, the US Food and Drug Administration (FDA) has authorized the administration of the Pfizer vaccine to people over the age of 12. A decision on the matter is expected in the coming days vaccinating children from 5 years of age.

In the United States, more than 57 percent of people are fully vaccinated. More than 66 percent have already taken at least one dose. The US FDA has approved three vaccines: Moderny, Pfizer / BioNTech, and Johnson & Johnson.

Main photo source: ETIENNE LAURENT / PAP / EPA

Source link

More articles

- Advertisement -

Latest article